Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PONTIAC II: RAS-antagonists and Beta-blockers for Cardiac Prevention in T2DM
NCT02817360Phase 4Recruiting
- Start
- Feb 2016
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of carvedilol in cardiovascular disease (CVD). Started Feb 2016; status: recruiting.
02
Drugs
carvedilol
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02817360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817360.